"In unserem Centrum für Angiologie und Kardiologie Frankfurt stehen die Erkennung und Behandlung von Erkrankungen des Herzens, des Herz-Kreislauf-Systems und der Gefäße im Vordergrund. Wir führen Ultraschalluntersuchungen, EKG-Untersuchungen sowie Herzkatheteruntersuchungen durch und nehmen minimal-invasive Eingriffe im Herzkatheterlabor vor. Im Rahmen der Angiologie behandeln wir Krankheiten der Arterien und Venen."

During the past decade, Cardiovascular Center Frankfurt conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Center Frankfurt" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Boston Scientific Corporation" with 2 trials sponsored, "pfm medical ag" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Ancora Heart, Inc." with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Center Frankfurt" #1 collaborator was "Genae" with 2 trials as a collaborator, "Aix Scientifics" with 1 trials as a collaborator, "AtriCure, Inc." with 1 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 1 trials as a collaborator and "Comed B.V." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Center Frankfurt" are "Atrial Fibrillation" (4 trials), "Stroke" (3 trials), "Mitral Regurgitation" (2 trials), "Type 2 Diabetes" (2 trials) and "Aortic Aneurysm, Abdominal" (1 trials). Many other conditions were trialed in "Cardiovascular Center Frankfurt" in a lesser frequency.

Most popular intervention types in "Cardiovascular Center Frankfurt" are "Device" (17 trials), "Drug" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Tirzepatide" (2 trials), "ASD and PDA closure" (1 trials), "AccuCinch® Ventriculoplasty System" (1 trials) and "Amplatzer Cardiac Plug" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Center Frankfurt" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Center Frankfurt". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Cardiovascular Center Frankfurt, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Center Frankfurt, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".

Cardiovascular Center Frankfurt has several departments that took part in Clinical trials: "CardioVasculäres Centrum Frankfurt" - 20 trials